Cite
HARVARD Citation
Tadbiri, S. et al. (2018). Impact of vedolizumab therapy on extra‐intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV‐IBD cohort. Alimentary pharmacology & therapeutics. 47 (4), pp. 485-493. [Online].